OPT (6U2) Stock Overview

Operates as a consulting and training company in Italy. More details

6U2 fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	5/6
Past Performance	0/6
Financial Health	4/6
Dividends	0/6

Rewards

Trading at 25.5% below our estimate of its fair value

Earnings are forecast to grow 87.72% per year

Revenue grew by 29.4% over the past year

Risk Analysis

Shares are highly illiquid

Does not have a meaningful market cap (€6M)

Less than 3 years of financial data is available

Does not have meaningful revenue (€2M)

6U2 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW477,689 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.

Grow your followingReal investors. The kind who actually invest, not scroll past.

Unlock free accessFree premium subscription for consistent and quality authors.

Learn more Create Narrative

477,689 investors already sharing narratives

View all narratives

OPT S.p.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for OPT
Historical stock prices
Current Share Price	€0.66
52 Week High	€0.73
52 Week Low	€0.66
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-7.19%

Recent updates

Shareholder Returns

	6U2	DE Healthcare	DE Market
7D	-7.1%	3.1%	0.1%
1Y	n/a	1.0%	-0.5%

Return vs Industry: Insufficient data to determine how 6U2 performed against the German Healthcare industry.

Return vs Market: Insufficient data to determine how 6U2 performed against the German Market.

Price Volatility

Is 6U2's price volatile compared to industry and market?
6U2 volatility
6U2 Average Weekly Movement	n/a
Healthcare Industry Average Movement	5.1%
Market Average Movement	5.3%
10% most volatile stocks in DE Market	12.7%
10% least volatile stocks in DE Market	2.7%

Stable Share Price: 6U2's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine 6U2's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1994	12	Davide Lucano	www.optsalute.it

OPT S.p.A. operates as a consulting and training company in Italy. It offers digital tools, such as E-PHARMA 360, a tool for healthcare facilities, hospital pharmacies, and community pharmacies that combines therapeutic algorithms, pharmacoeconomic, outcomes, and patient quality of life; E-NUTRITION, a multidisciplinary tool for the analysis of the nutritional support process for the oncology patient; e-TMD, a digital tool for healthcare facilities that allows the digitalization of the activities; HGI, a platform for healthcare facilities for the measurement and evaluation of key performance indicators of the patient journey; and 3G, a tool for general practitioners, territorial specialists, and hospital specialists for the integration of the PDTA. It also provides digital solutions to support the clinical and organizational governance of healthcare facilities; and delivers and organizes residential, FSC, and blended training sessions.

OPT S.p.A. Fundamentals Summary

How do OPT's earnings and revenue compare to its market cap?
6U2 fundamental statistics
Market cap	€5.65m
Earnings (TTM)	-€19.51k
Revenue (TTM)	€2.48m

2.3x

P/S Ratio

-289.4x

P/E Ratio

Is 6U2 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6U2 income statement (TTM)
Revenue	€2.48m
Cost of Revenue	€1.90m
Gross Profit	€580.16k
Other Expenses	€599.67k
Earnings	-€19.51k

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	-0.0026
Gross Margin	23.35%
Net Profit Margin	-0.79%
Debt/Equity Ratio	32.3%

How did 6U2 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/07/22 02:19
End of Day Share Price	2026/07/22 00:00
Earnings	2025/12/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

OPT S.p.A. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Mattia Petracca	Integrae SPA

OPT S.p.A.DB:6U2 Stock Report